Scope of worldwide hepatitis C problem

Liver Transplantation

Volumn 9, Issue 11, 2003, Pages

  Brown Jr , Robert S ^a   Gaglio, Paul J ^a  

^a New York Presbyterian Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DEVELOPED COUNTRY; DISEASE COURSE; DISEASE TRANSMISSION; ECONOMIC ASPECT; GENETICS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH; HEALTH CARE COST; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER FAILURE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; VIRAL CONTAMINATION; VIRUS TRANSMISSION;

EID: 0242456086     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50244     Document Type: Article

References (30)

1. Heintges T, Wands JR. Hepatitis C virus: Epidemiology and transmission. Hepatology 1997;26:521-526.
2. Centers for Disease Control and Prevention. Hepatitis A to E. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/httoc.htm. Accessed May 21, 2001.
3. National Institutes of Health. Chronic Hepatitis C: Current Disease Management. US Department of Health and Human Services: Bethesda, MD; 1999. NIH publication no. 99-4230.
4. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26(suppl 1):62S-65S.
5. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562.
6. National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C. Hepatology 1997;26(suppl 1):2S-10S.
7. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States. Hepatology 2000;31:777-782.
8. Sterling RK, Shiffman ML. Acute and chronic viral hepatitis. In: Rakel RE, ed. Conn's Current Therapy 2000. Philadelphia: Saunders; 2000: 501-507.
9. Prati D, Capelli C, Silvani C, De Mattei C, Bosoni P, Pappalettera M, et al. The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors. Hepatology 1997;25:702-704.
10. Noguchi S, Sata M, Suzuki H, Mizokami M, Tanikawa K. Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection. Scand J Infect Dis 1997;29:23-28.
11. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy. Hepatology 1997;26:1006-1011.
12. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355:887-891.
13. Kiyosawa K, Tanaka E, Sodeyama T, et al. Transmission of hepatitis C in an isolated area in Japan: Community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology 1994;106:1596-1602.
14. McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. J Clin Microbiol 1994;32:884-892.
15. Dusheiko G, Schmilovitz-Weiss H, Brown D, et al. Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease. Hepatology 1994;19:13-18.
16. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998; 47:1-39.
17. Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-356.
18. Wong JB. Cost-effectiveness of treatments for chronic hepatitis C. Am J Med 1999;107:74S-78S.
19. Roudot-Thoraval F, Bastie A, Pawlotsky JM, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology 1997;26:485-490.
20. Niederau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study. Hepatology 1998;28:1687-1695.
21. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999;340:1228-1233.
22. Gordon SC, Bayati N, Silverman AL. Clinical outcome of hepatitis C as a function of mode of transmission. Hepatology 1998; 28:562-567.
23. Hu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology 1999;29: 1311-1316.
24. Wiese M, Berr F, Lafrenz M, Porst H, Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: A 20-year multicenter study. Hepatology 2000;32: 91-96.
25. Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996;23:1334-1340.
26. El Serag H, Mason A. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
27. Kiyosawa K, Tanaka E. Characteristics of hepatocellular carcinoma in Japan. Oncology 2002;62(suppl 1):5-7.
28. Di Bisceglie AM. Liver transplantation for hepatitis C: The promise and the challenge. Hepatology 1995;22:660-662.
29. American Gastroenterological Association. The Burden of Gastrointestinal Diseases. Bethesda, MD: American Gastroenterological Association; 2001.
30. World Health Organization. Hepatitis C, 2002. Available at: http://www.who.int/ith/chapter05_m05_hepatitis.html. Accessed September 22, 2003.